Skip to main content

Table 7 Impact of purchase gaps when up to 6 months of ectoparasite protection is purchased with gaps

From: An assessment of canine ectoparasiticide administration compliance in the USA

Product

Six-month dosing period including average gap duration (weeks)

Percentage of period protected

Fluralaner 12-week dosing

36.8

65

Fluralaner 8-week dosing

58.1

55

Afoxolaner

71.4

36

Sarolaner

103.6

25

Lotilaner

56.0

46

  1. For dosing intervals of fluralaner, see Table 6